PHARMA

0.360

+0.005 (+1.4%)

Change in Boardroom

PHARMANIAGA BERHAD

Date of change 01 Mar 2021
Name DATO' SRI MOHAMMED SHAZALLI BIN RAMLY
Age 59
Gender Male
Nationality Malaysia
Designation Chairman
Directorate Non Independent and Non Executive
Type of change Appointment

Qualifications

No
Qualifications
Major/Field of Study
Institute/University
Additional Information
Masters
Business Administration
St. Louis University, Missouri, USA
Degree
Bachelor of Science (Marketing)
Indiana University Bloomington, Indiana USA
Diploma
Diploma
Universiti Teknologi MARA Perlis

Working experience and occupation
-   1 December 2020 to present - Group Managing Director, Boustead Holdings Berhad.
-   April 2017 to June 2018 - Managing Director/Chief Executive Officer, Telekom Malaysia Berhad.
-   2016 to 2017 - Regional Chief Executive Officer and Corporate Executive Vice President, Axiata Group 
    Berhad.
-   2005 to 2016 - Chief Executive Officer and Director, Celcom Axiata Berhad.
-   1998 to 2005 - Chief Executive Officer, NTV7.
-   1996 to 1997 - Marketing Director, ASTRO.
-   1993 to 1996 - Group Brand International Marketing Manager, Malaysian Tobacco Company and British 
     American Tobacco.
-   1987 to 1993 - Group Brand Manager, Unilever.
Directorships in public companies and listed issuers (if any)
Boustead Holdings Berhad
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Nil



Remarks :
Dato' Sri Mohammed Shazalli bin Ramly has been appointed as Chairman of Pharmaniaga Berhad with effect from 1 March 2021.


Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 01 Mar 2021
Category Change in Boardroom
Reference Number C03-01032021-00002